Oral Immune-Related Adverse Events – Current Concepts and their Management

Recent advent of immune checkpoint inhibitors (ICIs) have made significant improvement in the treatment outcome of cancer patients. They are also known to increase the overall survival in many malignancies. They target key immune checkpoints, acting on the cytotoxic T-lymphocyte antigen-4, programme...

Full description

Bibliographic Details
Main Authors: Mohamed Faizal Asan, Renita Lorina Castelino, Subhas G Babu, Kumuda Rao, Vaibhav Pandita
Format: Article
Language:English
Published: Elsevier 2021-01-01
Series:Asia-Pacific Journal of Oncology Nursing
Subjects:
Online Access:http://www.apjon.org/article.asp?issn=2347-5625;year=2021;volume=8;issue=6;spage=604;epage=609;aulast=Asan